We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Engineering the Future of Genetic Medicine
Industry Insight

Technology Networks recently interviewed Benjamin Oakes, co-founder, president and CEO at Scribe, to learn more about the company's next steps in "fulfilling the promise of CRISPR" and how it will navigate some of the challenges associated with developing CRISPR-based therapeutics, including efficacy, scale-up and high costs.

Read More

Miniature Columns, Massive Insights: The Transformative Potential of Automation for Purification
Industry Insight

A novel combination of miniaturized purification technology, automation and software presents an opportunity to drastically shorten drug or vaccine development timelines by rethinking how purification processes are refined.

Read More

A Step in the Right Direction for Dioxin Detection
Industry Insight

To detect, quantify and ultimately instigate remedial action in relation to dioxin contamination, scientists require suitable analytical tools and techniques. The USEPA recently approved a new dioxin testing method which could assist these efforts. We spoke to Frank L. Dorman, PhD, FRSC, about the hazards posed by dioxins, challenges in their identification and the future detection landscape.

Read More

The Development of Natural Killer Cells for Solid Tumor Treatment
Industry Insight

We interviewed Jan Davidson MD., PhD., the newly appointed chief medical officer at Wugen to learn more about the company's agreement with Washington University to further their Memory NK Cell program.

Read More

The Evolving Problem of Microplastics in a PPE Era
Industry Insight

Microplastics are now ubiquitous in our lives and environment. To compound the problem, the advent of COVID-19 has seen uptake of single-use plastics in the form of personal protective equipment (PPE) skyrocket. We spoke to Kathleen A. Young about how the microplastics issue has evolved in light of COVID-19, particularly around PPE waste and what gains are being made in the areas of testing and analysis standards.

Read More

Combining AI and Point-of-Care Diagnostics for Rapid COVID-19 Screening
Industry Insight

Technology Networks interviewed Dr Andrew Soltan, NIHR Academic Clinical Fellow at the John Radcliffe Hospital, to learn more about the CURIAL algorithm and how it is being used alongside Sight OLO, Sight Diagnostics’ machine vision-based blood analyzer, to rapidly triage patients and support infection control within hospitals.

Read More

Looking Towards a Digital Future for Analytical Chemistry Post-COVID-19
Industry Insight

We spoke to ACD/Labs, which specializes in informatics platforms for analytical data handling. Andrew Anderson, ACD/Labs’ vice president for innovation and informatics strategy, outlined the challenges analytical chemists have faced during the pandemic and how informatics tools can help to make digital strategies, both remote and in the lab, more streamlined.

Read More

Supporting Scientists Responding to the COVID-19 Pandemic
Industry Insight

The development and implementation of efficient tests is crucial in efforts to reduce the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Read More

An Automated Age for Western Blotting
Industry Insight

Western blotting has been a core technique in molecular biology for many years, however, optimization and reproducibility can be problematic. We spoke to Dr Alexandre Lucas about the automation of western blotting and the difference this advance is making to research.

Read More

How Can Artificial Intelligence Stop the Spread of Antimicrobial Resistance?
Industry Insight

As we begin to see the light at the end of the COVID-19 pandemic, the threat of antimicrobial resistance has not gone away and remains a priority. Precision medicine company OpGen use molecular diagnostics and informatics to identify AMR before it can spread. To find out more, Technology Networks caught up with OpGen's CEO Oliver Schacht.

Read More

 
Advertisement